首页> 外文期刊>Clinical infectious diseases >Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States
【24h】

Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States

机译:在美国实施一项监测住院抗菌药物使用情况的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Measuring antimicrobial use is an important way to provide metrics that support more vigorous, facility-specific stewardship efforts, which in turn will be a major step toward reducing unnecessary use of broad-spectrum antimicrobials. Yet no single system is available in the United States that can meet stewardship needs at the level of individual hospitals and provide benchmarks, monitor trends, and measure the magnitude of antimicrobial use at the regional, state, and national levels. Therefore, the Centers for Disease Control and Prevention is pursuing 3 distinct and complimentary efforts that remain focused on providing "data for action," including facilitylevel use metrics for benchmarking across comparable patient care settings, national estimates of usage patterns using sentinel surveillance sites, and limited assessments using proprietary data.
机译:衡量抗菌药物的使用是提供指标以支持更加有力的,针对特定设施的管理工作的重要方法,而这反过来又将是减少不必要的广谱抗菌药物使用的重要一步。但是,在美国,没有一个单一的系统可以满足各个医院级别的管理需求,并且无法提供基准,监控趋势并在地区,州和国家级别上衡量抗菌药物的使用量。因此,疾病控制与预防中心正在进行3项独特而互为补充的工作,这些工作仍致力于提供“行动数据”,包括在可比较的患者护理环境中进行基准测试的设施级别使用指标,使用前哨监视站点的全国使用模式估计以及使用专有数据进行的有限评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号